These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38235142)

  • 1. Chemical immune conization of precancerous cervical lesions awakens immune cells and restores normal HPV negative and abnormal proliferation.
    Liu X; Yu B; Gao F; Jing P; Zhang P; Zheng G; Zhang X
    Front Immunol; 2023; 14():1259723. PubMed ID: 38235142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
    Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
    Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome.
    Guo C; Qu X; Tang X; Song Y; Wang J; Hua K; Qiu J
    Clin Transl Med; 2023 Mar; 13(3):e1219. PubMed ID: 36967539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative predictive value of human papillomavirus test following conization of the cervix uteri.
    Jain S; Tseng CJ; Horng SG; Soong YK; Pao CC
    Gynecol Oncol; 2001 Jul; 82(1):177-80. PubMed ID: 11426982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
    Nagai Y; Maehama T; Asato T; Kanazawa K
    Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Global guidelines for cervical cancer and precancerous lesions treatment: a systematic review].
    Zhao S; Chen H; Zhao FH
    Zhonghua Yi Xue Za Zhi; 2022 Jun; 102(22):1666-1676. PubMed ID: 35692019
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficiency of three surgical procedures in eliminating high-risk human papillomavirus infection in women with precancerous cervical lesions.
    Jancar N; Rakar S; Poljak M; Fujs K; Kocjan BJ; Vrtacnik-Bokal E
    Eur J Gynaecol Oncol; 2006; 27(3):239-42. PubMed ID: 16800249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status.
    Sand FL; Kjaer SK; Frederiksen K; Dehlendorff C
    Int J Cancer; 2020 Aug; 147(3):641-647. PubMed ID: 31648368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Leukocyte Antigen-G (HLA-G) Expression in Precancerous and Cancerous Cervical Lesions: Association with Human Papilloma Virus Infection and Host Immune Response.
    Fahim NM; Shehata IH; Taha SE; Fahmy RA; Elsayed MS
    Egypt J Immunol; 2018 Jan; 25(1):125-134. PubMed ID: 30243004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
    Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results.
    Bodner K; Bodner-Adler B; Wierrani F; Kubin A; Szölts-Szölts J; Spängler B; Grünberger W
    Anticancer Res; 2003; 23(2C):1785-8. PubMed ID: 12820459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
    Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the Association between the Fibroblast Growth Factor Receptor 4 Expression and High-Risk Human Papillomavirus Infection in Cervical Cancer and Precancerous Lesions.
    Guo L; Zhao A; Zhang R; Xie Y; Xu X
    Gynecol Obstet Invest; 2018; 83(6):608-614. PubMed ID: 29982249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
    Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
    Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China.
    Feng RM; Z Wang M; Smith JS; Dong L; Chen F; Pan QJ; Zhang X; Qiao YL; Zhao FH
    J Clin Virol; 2018; 99-100():84-90. PubMed ID: 29396352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conization as a marker of persistent cervical human papillomavirus (HPV) infection and risk of gastrointestinal cancer: a Danish 34-year nationwide cohort study.
    Kirkegård J; Farkas DK; Søgaard M; Schmidt SA; Ostenfeld EB; Cronin-Fenton D
    Cancer Causes Control; 2014 Dec; 25(12):1677-82. PubMed ID: 25303999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.